In conclusion, upregulated SphK-S1P expression can aggravate gut inflammation by modulating the composition of the gut microbiota, resulting in the development of IBD, and intestinal bacteria can also affect the level of S1P in IECs through mutual interactions. The gene discussed is MBTPS1; the disease is inflammatory bowel disease.